Fudim, Marat
Sarma, Satyam
MacNamara, James P.
Ascheim, Deborah D.
Kittipibul, Veraprapas
Doukellis, Katheryn
Dhimitri, Andy
Fitzhugh, Robert
Kamat, Niharika
Costa, Kevin D.
Rudy, Jeffrey
Guerrero, Janet
Chan, Camie
Li, Ronald A.
Bavry, Anthony A.
Patel, Manesh R.
Grodin, Justin L.
Levine, Benjamin D.
Hajjar, Roger J.
Article History
Received: 3 October 2025
Revised: 1 December 2025
Accepted: 7 December 2025
First Online: 17 January 2026
Declarations
:
: Niharika Kamat, PhD, Kevin D. Costa, PhD, Jeffrey Rudy, PhD, Janet Guerrero, PhD, Camie Chan, PhD, Ronald A. Li, PhD, Roger J. Hajjar, MD are employees of Medera Biopharma, the sponsor of the clinical trial. Deborah D. Ascheim, MD is a consultant for Medera Biopharma. Marat Fudim, MD, MHS, Satyam Sarma, MD, James P. MacNamara, MD, MSCS, Katheryn Doukellis, BS, Justin L. Grodin, MD, MPH, Benjamin D. Levine, MD have been supported by Medera as site investigators. All other authors declare no relevant disclosures.
: Niharika Kamat, PhD, Kevin D. Costa, PhD, Jeffrey Rudy, PhD, Janet Guerrero, PhD, Camie Chan, PhD, Ronald A. Li, PhD, Roger J. Hajjar, MD are employees of Medera Biopharma, the sponsor of the clinical trial. Deborah D. Ascheim, MD is a consultant for Medera Biopharma. Marat Fudim, MD, MHS, Satyam Sarma, MD, James P. MacNamara, MD, MSCS, Katheryn Doukellis, BS, Justin L. Grodin, MD, MPH, Benjamin D. Levine, MD have been supported by Medera as site investigators. All other authors declare no relevant competing interests.